Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (1-10 of 347) with videos related to

Pageof 35
Sort By:
The New England Journal of Medicine|December 18, 2024
Durvalumab in Small-Cell Lung Cancer. ReplySuresh Senan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
Staging nodal disease in non-small cell lung cancer: implications for radiation therapySuresh Senan
The Lancet. Oncology|March 4, 2021
The elusive pursuit of progress in limited stage small-cell lung cancerSuresh Senan
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Reply to "Radiation pneumonitis and docetaxel"Suresh Senan
Current Opinion in Oncology|February 26, 2003
Indications and limitations of radiotherapy in malignant pleural mesotheliomaSuresh Senan
Journal of Oncology Practice|July 14, 2016
Treatment of Stage IIIA Non-Small-Cell Lung Cancer: Charting the Next StepsSuresh Senan
Onkologie|August 1, 2012
Stereotactic body radiotherapy: do central lung tumors still represent a 'no-fly zone'?Suresh Senan
Cancer|April 23, 2013
Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoiseSuresh Senan
Translational Lung Cancer Research|September 18, 2015
Exploring controversies in lung cancer using structured pro-con debatesSuresh Senan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2013
Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable?Suresh Senan, Sashendra Senthi
Pageof 35

Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
The New England Journal of Medicine|December 18, 2024
Durvalumab in Small-Cell Lung Cancer. ReplySuresh Senan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
Staging nodal disease in non-small cell lung cancer: implications for radiation therapySuresh Senan
The Lancet. Oncology|March 4, 2021
The elusive pursuit of progress in limited stage small-cell lung cancerSuresh Senan
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Reply to "Radiation pneumonitis and docetaxel"Suresh Senan
Current Opinion in Oncology|February 26, 2003
Indications and limitations of radiotherapy in malignant pleural mesotheliomaSuresh Senan
Journal of Oncology Practice|July 14, 2016
Treatment of Stage IIIA Non-Small-Cell Lung Cancer: Charting the Next StepsSuresh Senan
Onkologie|August 1, 2012
Stereotactic body radiotherapy: do central lung tumors still represent a 'no-fly zone'?Suresh Senan
Cancer|April 23, 2013
Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoiseSuresh Senan
Translational Lung Cancer Research|September 18, 2015
Exploring controversies in lung cancer using structured pro-con debatesSuresh Senan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2013
Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable?Suresh Senan, Sashendra Senthi
Pageof 35